Besides SH2B3 suggested by many studies, three lines of evidence support the role of ATXN2 (Table 1, Supplementary Table S4), including the results of the study on ataxin-2 knock-out mice (such animals displayed different pathological changes such as obesity and increased serum cholesterol level65). Here, ATXN2 is linked to obesity disorder.